PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2011; 6(7): e22564.
Published online Jul 27, 2011. doi:  10.1371/journal.pone.0022564
PMCID: PMC3144892
Spermidine Promotes Human Hair Growth and Is a Novel Modulator of Human Epithelial Stem Cell Functions
Yuval Ramot,#1,2 Stephan Tiede,#2 Tamás Bíró,3 Mohd Hilmi Abu Bakar,2,4 Koji Sugawara,2 Michael P. Philpott,5 Wesley Harrison,5 Marko Pietilä,6 and Ralf Paus2,7*
1Department of Dermatology, Hadassah - Hebrew University Medical Center, Jerusalem, Israel
2Department of Dermatology, University of Lübeck, Lübeck, Germany
3Department of Physiology, Research Centre for Molecular Medicine, University of Debrecen, Debrecen, Hungary
4Universiti Sains Malaysia, Kelantan, Malaysia
5Centre for Cutaneous Research, Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
6Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, Biocenter Kuopio, University of Eastern Finland, Kuopio, Finland
7Epithelial Sciences, School of Translational Medicine, University of Manchester, Manchester, United Kingdom
Jürgen Schauber, Editor
Ludwig-Maximilian-University, Germany
#Contributed equally.
* E-mail: ralf.paus/at/uk-sh.de
Conceived and designed the experiments: YR ST TB MPP RP. Performed the experiments: YR ST TB MHAB KS MPP WH. Analyzed the data: YR ST TB MHAB KS MPP WH. Contributed reagents/materials/analysis tools: MP. Wrote the paper: YR ST MPP RP MP TB KS WH.
Received April 15, 2011; Accepted June 24, 2011.
Background
Rapidly regenerating tissues need sufficient polyamine synthesis. Since the hair follicle (HF) is a highly proliferative mini-organ, polyamines may also be important for normal hair growth. However, the role of polyamines in human HF biology and their effect on HF epithelial stem cells in situ remains largely unknown.
Methods and Findings
We have studied the effects of the prototypic polyamine, spermidine (0.1–1 µM), on human scalp HFs and human HF epithelial stem cells in serum-free organ culture. Under these conditions, spermidine promoted hair shaft elongation and prolonged hair growth (anagen). Spermidine also upregulated expression of the epithelial stem cell-associated keratins K15 and K19, and dose-dependently modulated K15 promoter activity in situ and the colony forming efficiency, proliferation and K15 expression of isolated human K15-GFP+ cells in vitro. Inhibiting the rate-limiting enzyme of polyamine synthesis, ornithine decarboyxlase (ODC), downregulated intrafollicular K15 expression. In primary human epidermal keratinocytes, spermidine slightly promoted entry into the S/G2-M phases of the cell cycle. By microarray analysis of human HF mRNA extracts, spermidine upregulated several key target genes implicated e.g. in the control of cell adherence and migration (POP3), or endoplasmic reticulum and mitochondrial functions (SYVN1, NACA and SLC25A3). Excess spermidine may restrict further intrafollicular polyamine synthesis by inhibiting ODC gene and protein expression in the HF's companion layer in situ.
Conclusions
These physiologically and clinically relevant data provide the first direct evidence that spermidine is a potent stimulator of human hair growth and a previously unknown modulator of human epithelial stem cell biology.
Polyamines (spermidine, putrescine and spermine) are multifunctional polycationic aliphatic amines, which serve crucial roles in cell survival. Besides serving as nutrients and metabolic regulators [1], [2], polyamines have been implicated as mediators of key cell functions, such as proliferation, migration and differentiation [3][7]. Polyamines also stabilize DNA/RNA and modulate DNA replication/transcription [1], [2], [8][10], and stabilize membrane and cytoskeletal proteins [11], [12]. Recently a key polyamine, spermidine, has even been hailed as a new longevity agent due to its impact on chromatin-mediated regulation of gene expression [13]. While polyamines are indispensable for cell proliferation, and are needed for the growth of rapidly regenerating tissues and tumors [14], [15], the full spectrum of functions of spermidine in normal human tissue physiology remains poorly understood [16].
The hair follicle (HF) is one of the most highly proliferative organs in mammalian biology [17], [18]. Therefore, polyamines have long been suspected to be important for hair growth [19]. For example, inhibiting polyamine synthesis significantly modulates murine hair growth [20], and polyamines have an essential role in determining sheep HF growth and diameter [21]. In addition, a recent study has shown that a topical administration of α-methylspermidine, a stable analogue of spermidine, induced hair growth in telogen phase mice [22]. Surprisingly, however, studies utilizing several transgenic mice lines with altered polyamine metabolism [6], [19], [20], [23][28] showed that the most prominent phenotype of these mice was hair loss due to disturbed proliferation of follicular keratinocytes.
In human skin, topical application of eflornithine (difluoromethylornithine, DFMO), an inhibitor of ornithine decarboxylase (ODC), the rate limiting enzyme in the polyamine biosynthesis pathway [29], can reduce undesired, excessive hair growth [30], [31]. We have previously shown that addition of DFMO to organ-cultured human scalp HFs shortens the growth phase of the hair cycle (anagen) and inhibits hair shaft production, accompanied by a decrease in matrix keratinocyte proliferation [32]. However, whether and how spermidine itself affects human hair growth directly is unknown.
Therefore, we have exploited the HF as an excellent model system for exploring physiological polyamine functions in human skin [29]. Specifically, we have studied in normal, microdissected human scalp HFs under serum-free organ culture conditions [33][35] whether spermidine impacts on basic hair biology parameters. We opted for testing the spermidine doses that have been previously shown to modulate wool follicles growth in organ culture [21], and that correspond to the physiological spermidine levels in human plasma [36]. Using keratin 15 (K15) expression and K15 promoter-driven green fluorescent protein (GFP) expression as a system for assessing human epithelial HF stem cell functions in situ and in vitro [35], [37], [38], we also explored whether spermidine alters human HF epithelial stem cell clonogenicity, whose modulation by polyamines is as yet unknown [17], [18], [38], [39].
Spermidine stimulates hair-shaft elongation and prolongs anagen
Administration of spermidine for 6 days slightly, but significantly, increased hair shaft growth of microdissected, organ-cultured normal human scalp HFs (Figure 1A). This effect was maximal and significant at 0.5 µM, and led to more than a 20% increase in hair shaft production after 6 days in culture (Figure 1B).
Figure 1
Figure 1
Spermidine treatment increases hair shaft elongation and prolongs anagen.
However, whether spermidine can also prolong the duration of anagen is clinically much more important than the effect on hair elongation since this directly impacts on the amount of hair that is shed (e.g., a reduced percentage of HFs in anagen, clinically, will inevitably result in a higher percentage of catagen and subsequently telogen HFs, thus leading to telogen effluvium – and vice versa) [17], [18], [40]. To assess this, quantitative hair cycle histomorphometry was performed [41], [42]. Indeed, after 6 days of organ culture, all doses of spermidine investigated led to an increase in the percentage of HFs in anagen, and decreased that of catagen HFs (Figure 1C). In the presence of spermidine, only 47–52% of the HFs spontaneously entered catagen, while 67% of the control HFs had already done so.
Spermidine downregulates ODC expression in the HF
ODC, the rate-limiting enzyme of polyamine synthesis, reportedly is expressed in highly proliferative hair matrix keratinocytes [29], [43]. We have also demonstrated that ODC is present in the matrix keratinocytes of human anagen VI HFs (Fig. 2A). However, surprisingly, high immunoreactivity was also evident in the companion layer of the HF (Fig. 2A).
Figure 2
Figure 2
Spermidine treatment down-regulates ODC expression in the HF.
Since polyamines negatively regulate ODC activity, both on transcriptional and post-transcriptional level [29], we checked whether any such effect is also apparent in spermidine-treated HFs. We found that spermidine treatment for 6 days downregulated ODC protein expression in situ (Figure 2B), and showed a tendency towards decreased ODC mRNA transcription after 24 h treatment (Figure 2C), though the latter was not significant. However, in isolated, cultured human HF-derived outer root sheath (ORS) keratinocytes, 0.5 µM spermidine treatment for 48 h significantly downregulated ODC mRNA expression (Figure 2D). Together, these data suggest that excess spermidine induces intracellular counter-regulatory events in human HF epithelium in situ through which further intrafollicular polyamine synthesis is restricted by inhibiting ODC gene and protein expression.
Spermidine stimulates human hair matrix and epidermal keratinocyte proliferation
The fact that spermidine prolonged anagen suggested effects on highly proliferative hair matrix keratinocytes [17], [18]. In situ, spermidine slightly, but not significantly stimulated hair matrix keratinocyte proliferation, as assessed by quantitative Ki67-immunohistomorphometry (Figure 3A), and did not significantly alter hair matrix keratinocyte apoptosis (Figure 3A). However, fluorimetric proliferation assays revealed that spermidine dose-dependently stimulated the proliferation of cultured primary human epidermal keratinocytes (Figure 2B). FACS analysis revealed that spermidine promoted the accumulation of cells in the S/G2-M phases of the cell cycle (data not shown). Thus, the promotion of S/G2-M entry by human HF keratinocytes may be one potential mechanism by which spermidine may exert its anagen-prolonging effects.
Figure 3
Figure 3
Spermidine stimulated proliferation of primary human keratinocytes and tended to stimulate hair matrix keratinocytes.
Spermidine differentially modulates the gene expression profile of human HFs
In order to identify potential (direct or indirect) target genes of spermidine action in human HFs, a genome-wide microarray analysis was performed on two independent sets of organ-cultured human scalp HFs, derived from two healthy female volunteers (aged 47 and 67 yrs), which had been treated with 0.5 µM spermidine or vehicle for 24 h and 48 h, respectively. In order to check which genes are being constitutively activated following spermidine administration, we made a comparison between these two time-points. Adopting rigid selection criteria, i.e. selecting only those genes whose intrafollicular transcription was modified >2-fold (p < 0.05) into the same direction in both individuals, only five genes were identified as significantly and equidirectionally up-regulated by the tested spermidine dose (Table 1). Of these spermidine-regulated genes, SYVN1 and NACA are known to be important for normal cell homeostasis and function, including endoplasmic reticulum-associated protein degradation [44] and folding and targeting of nascent proteins [45]. SLC25A3 encodes a mitochondrial phosphate carrier, essential for the aerobic synthesis of adenosine triphosphate [46], and POP3 is important for cell adherence and migration [47] (see Discussion for details).
Table 1
Table 1
Selected genes up-regulated in HFs by spermidine (0.5 µM).
Spermidine up-regulates expression of the epithelial stem cell-associated keratins K15 and K19, and modulates K15 promoter activity in situ
Anagen maintenance requires constant production of HF keratinocytes from resident epithelial stem cells (eSCs) and their progeny, which are thought to migrate towards the hair matrix [18], [48]. Since polyamines have been shown to be required for the migration [3], [4] and differentiation of various progenitor cell populations [5][7], [49] as well as for cell cycle progression [50], [51], we therefore addressed whether spermidine also affects human HF eSCs. These cells are located primarily in the bulge and are characterized by expression of K15; however, K15+ progenitors are also found further down the ORS [17], [18], [38], [39].
Even though our microarray analysis had not identified any HF-associated keratins as spermidine-regulated genes (possibly for methodological or sub-threshold reasons), quantitative immunohistomorphometry of K15 expression in situ clearly showed that spermidine significantly increased K15 immunoreactivity in the basal layer of the proximal ORS after 6 days (Figure 4A).
Figure 4
Figure 4
Spermidine up-regulates expression of the epithelial stem cell-associated keratins K15 and K19.
To confirm this effect in isolated human HF keratinocytes, which are not influenced by the HF mesenchyme, HF melanocytes, and intrafollicular hematopoietic cells, we measured the steady-state levels of K15 mRNA in cultured human ORS keratinocytes that had been treated for 48 h with 0.5 µM spermidine. Indeed, K15 mRNA was upregulated after 48 h of treatment (Figure 4B). Conversely, ODC inhibition by DMFO significantly downregulated K15 expression after 6 days (Figure 4C). This suggests that K15 protein expression in situ is profoundly regulated by spermidine.
In the lower two doses tested, spermidine also significantly increased keratin 19 (K19) protein expression after 6 days, an independent human HF epithelial progenitor cell marker [35], [52] (Figure 4D). Additionally, 0.5 µM spermidine administration led to increased K19 mRNA expression in organ-cultured HFs after 24 h (Figure 4E). Treatment of cultured ORS keratinocytes with 0.5 µM spermidine tended to upregulate K19 mRNA after 48 h, but this was not statistically significant (Figure 4F).
To further explore the effect of spermidine on human HF eSCs in the bulge [39], [48], we employed a novel human K15 promoter-driven GFP reporter assay, which demarcates K15+ human HF epithelial progenitor cells in situ [37], [38]. This revealed that spermidine also significantly and dose-dependently modulated human K15 promoter activity in the bulge region in situ: As measured by the intensity of GFP fluorescence, at 0.5 µM spermidine up-regulated the transfected K15 promoter activity in situ, while it down-regulated it at 0.1 µM or 1 µM (Figure 5A).
Figure 5
Figure 5
Spermidine modulates colony forming efficiency and K15 expression of isolated K15-GFP+ cells in vitro.
Spermidine dose-dependently modulates colony forming efficiency and K15 expression of isolated K15-GFP+ cells in vitro
To further investigate how spermidine impacts on human HF epithelial progenitor cells in the absence of HF mesenchyme, HF melanocytes and intrafollicular hematopoietic cells, we isolated and cultured human HF K15-GFP+ progenitor cells [37], [38]. These experiments showed that only the 0.5 µM spermidine dose significantly up-regulated the colony forming efficiency of K15-GFP+ progenitor cells (Figure 5B). This spermidine dose also increased their K15 mRNA expression on days 3 and 6 (Figure 5C), and slightly enhanced their K15 protein expression on days 1 and 3 (Figure 5D). Furthermore, 0.5 µM spermidine also stimulated proliferation on days 3 and 6 of these isolated human HF progenitor cells in vitro (Figure 5D). In contrast, 1 µM spermidine significantly inhibited K15 mRNA expression and the proliferation activity of K15-GFP+ cells in vitro (Figures 5C, D).
These in vitro results are comparable with the in situ observations, which also showed maximal spermidine growth-modulatory effects on the intact HF mini-organ at the same dose. Taken together, this suggests that the spermidine-induced growth-promotion of human HFs at 0.5 µM (Figures 1A, B) may be mediated, at least in part, by an effect on epithelial HF progenitor cells, which are also stimulated by the same dose.
While it has long been postulated that polyamines may stimulate hair growth [22], [29], [53], the current study is the first to provide direct evidence that this is actually the case in human HFs. Specifically, we demonstrate that spermidine stimulates hair shaft elongation, accompanied by prolongation of anagen, and thus directly promotes human HF growth. This is in line with recent in vivo evidence that topically applied alpha-methylspermidine induces anagen in mouse telogen HFs [22].
The anagen prolongation/catagen inhibition by spermidine demonstrated here is clinically important: If our human HF organ culture data are transferrable to the in vivo situation, spermidine administration may help to counteract multiple forms of hair loss associated with excessive hair shedding. Namely, topical or nutraceutical spermidine application may reduce telogen effluvium in patients that suffer from hair loss due to premature anagen termination (e.g. by androgens, perifollicular inflammation, iron or estrogen deficiency, or effluvium-inducing drugs) [17], [54].
ODC is expressed in the anagen hair matrix [29], [55], and reducing intrafollicular spermidine synthesis by the inhibition of ODC activity reduces human hair shaft growth and shortens anagen duration [32]. Together with the anagen-prolonging and hair growth-promoting effects of spermidine demonstrated here, this suggests that intrafollicular synthesis of spermidine is important for keeping a HF in its growth stage. However, over-expression of ODC in mice results in the formation of dermal cysts, leading to the opposite effect ( = hair loss) [20], [25]. This is postulated to result from the excessive accumulation of putrescine, which causes disturbed keratinocyte differentiation and increased proliferation. In fact, we show here that spermidine application downregulates intrafollicular ODC expression on the gene and protein levels (Fig. 2B-D), and may thus protect the human scalp HF against excessive synthesis of putrescine so as to avoid deleterious polyamine effects on human hair growth.
To our surprise, although also evident in the proliferating keratinocytes of the hair bulb, the strongest expression of ODC was evident in the companion layer of the HF (Fig. 2A). This expression pattern coincides with the intriguing pattern of expression of K6/K16, the keratins known to be expressed in highly proliferating cells [56]. Thus, our findings add to the mystery which still surrounds this layer in the HF, and which awaits further investigation.
Despite the known general proliferation-stimulatory properties of polyamines [57], [58], which were confirmed here in cultured human epidermal keratinocytes (Fig. 3B), and the demonstrated inhibitory effects of DFMO on human hair matrix keratinocytes [32], spermidine exerted only minor effects on hair matrix proliferation in situ. Therefore, much of the stimulatory effect of spermidine on hair shaft production appears to arise from a prolongation of anagen (Fig. 1C). This supports the concept that polyamines are potent regulators of HF cycling, not only in mice [19], [22], [26], but also in man. It also provides the first evidence that one defined polyamine, spermidine, alters HF cycling by direct effects on the HF which are independent of extrafollicular changes induced in the concentration of various polyamines and/or in the activity of their multiple different target genes.
The recent provocative report that spermidine may promote longevity [13], [59] may be relevant in the current context, if one considers that, with the notable exception of its pigmentary unit, the HF is one of the most strikingly aging-resistant organs of the human body [60]. Furthermore, the duration and prolongation of anagen is a very faithful indicator of HF vitality [32], [61]. Therefore, one wonders whether spermidine impacts positively on a HF's individual lifespan. Since the latter vitally depends on its epithelial stem cell compartment [48], [62], this raises the question whether the normal function of HF epithelial stem cells depends on proper intrafollicular spermidine synthesis and/or availability.
Though our pilot study was not designed to provide definitive proof for the validity of this hypothesis, our current data suggest that human HF epithelial stem cells are profoundly modulated by spermidine: Spermidine not only upregulates K15 and K19 protein expression in situ (Fig. 4A,D), but intrafollicular spermidine synthesis is also needed for normal K15 expression (Figure 4C). Moreover, one tested spermidine dose (0.5 µM) stimulated K15 promoter activity and colony forming efficiency and long-term proliferation of isolated, primary human HF epithelial progenitors (Fig. 5A,B,D). Our observation that the highest tested dose of spermidine (1 µM) inhibited colony forming efficiency, K15 promoter activity, and proliferation at day 6, might well result from the metabolism of excess spermidine to toxic compounds that enhance oxidative damage, such as hydrogen peroxide [29].
Although strong upregulation of K15 was evident in all of our experiments at the 0.5 µM dose, K15 protein expression of K15-GFP+ cells in vitro was surprisingly downregulated on day 6 (Fig. 5D). This was in contrast to the upregulation of the corresponding mRNA expression that was observed at the same dose (Fig. 5C). It is possible that the rapid proliferation of the K15-GFP+ cells observed after 6 days of 0.5 µM spermidine administration (as assessed by Ki-67 immunoreactivity, Fig. 5D) did not allow enough time for the K15 protein to assemble in the cells, and to reach the level of detection. It has also been shown before that polyamines have an effect on the post-translational regulation of proteins, affecting protein degradation by direct or indirect effect on proteases [63]. Therefore, changes in protein expression may not always correlate with the changes observed at the mRNA level.
Our study presents the first evidence that spermidine is a novel determinant in human eSCs biology, most notably of K15 and K19 expression by primary human epithelial progenitor cells in situ and in vitro. These findings are in line with the prior demonstration that ODC is expressed in the bulge region of the HF [55], [64], where it colocalizes with that of K15 and K19 expression [52]. While polyamines are known to affect the keratin composition of wool follicles [21], it was previously unknown that polyamines actually regulates the expression of human eSC-associated keratins.
Moreover, we provide the first available evidence that inhibiting the key enzyme of polyamine synthesis (ODC) down-regulates K15 expression. Thus K15 expression in situ is profoundly regulated by spermidine, and both polyamines and ODC activity impact on the expression of this HF epithelial progenitor cell marker keratin. Our finding that ODC expression on the gene and protein level (and thus likely ODC activity) underlies a negative, dose-dependent feedback regulation by spermidine (Fig. 2B) underscores the apparent importance of keeping intrafollicular polyamine synthesis in check. That the highest dose of spermidine tested did not reduce ODC expression (Figure 1B) may suggest that adequate ODC activity remains needed as a part of the biological stress response to excessive spermidine levels.
We had hoped to obtain specific leads from our microarray analysis on how spermidine may exert its anagen-prolonging, stem cell-modulatory, and K15/K19-regulatory effects. While these results identified five novel intrafollicular candidate target genes for spermidine-mediated signaling (Table 1) that have not yet been investigated in the spermidine literature, these genes do not sufficiently explain the underlying mechanisms of action. However, the fact that the identified candidate genes are important for vital cell organelles and cell homeostasis fits well to the general concept that spermidine supports HF and eSC vitality.
For example, synoviolin (coded by SYVN1) is a ubiquitin ligase, which plays an important role in endoplasmic reticulum-associated protein degradation [44], the NACA gene encodes the nascent-polypeptide-associated complex alpha polypeptide, a part of the protein translation chaperone complex [45], and SLC25A3 is a mitochondrial phosphate carrier, which is essential for the aerobic synthesis of adenosine triphosphate [65]. Particularly interesting potential spermidine target gene is POP3, which belongs to the highly conserved popeye domain-containing family, and has been implicated in cell adherence and migration [47]. Although these microarray results could not be further validated since all available HF samples and sections had been consumed for the analyses reported here, our preliminary data provide new leads to previously unsuspected (direct or indirect) spermidine target genes in human tissue physiology.
An intriguing chance observation of our study was the finding that spermidine clearly up-regulated transcription of K77 in the HFs of two female patients (Table 1). Since this keratin has previously been claimed to be exclusively expressed in eccrine glands, we are now following this lead up on the gene and protein level in order to obtain deeper insights into the unexpected and enigmatic functions that K77 may have in human HF biology, and why expression of this gene is so spermidine-sensitive.
In summary, our study provides the first evidence that spermidine directly impacts on the growth, cycling, keratin expression and epithelial progenitor functions of human HFs. Due to its anagen-prolonging effects, spermidine deserves rigorous clinical testing as a candidate anti-hair loss agent. It could become an adjuvant therapy for hair loss disorders associated with premature catagen induction, leading to telogen effluvium, and/or reduced hair shaft production. Moreover, we show that the complex regulatory role of polyamines in human epithelial biology in situ extends far beyond the mere stimulation of proliferation. Our study also documents that, to further dissect the full range of polyamine functions in normal human tissue physiology, human HF organ culture offers a highly instructive, clinically relevant research tool (34).
HF organ culture
Anagen VI HFs were microdissected from normal temporofrontal human scalp skin obtained after written informed patient consent from ten healthy adult females undergoing routine facelift surgery, adhering to the Helsinki guidelines and following approval by the Institutional Research Ethics Committee of the University of Lübeck. In this clinically highly relevant in vitro-assay, amputated HFs in the growth phase of the hair cycle (anagen) continue for several days to produce a pigmented hair shaft at almost the normal speed of normal anagen HFs in vivo, and display cyclic growth activity in vitro by spontaneously entering into the regression phase of the hair cycle (catagen). For immunohistochemical studies, isolated HFs from four individuals were used for routine 6-day HF organ culture as previously described [17], [18], [32]-[35]. Spermidine (0.1, 0.5 or 1 µM), DFMO (400 mg/l) or vehicle (distilled water) were administered once for each change of culture medium (every 48 h). After 6 days, all test and control HFs were embedded, snap-frozen, and processed for longitudinal cryosectioning. The frozen sections were stored at −80°C until used. HFs from one individual were used for a 24 h organ culture, and utilized for a genome-wide microarray essay and quantitative PCR (qPCR). HFs from four additional individuals were subjected to 48 h organ cultures. HFs from two individuals were used for K15 promoter-driven green fluorescent protein (GFP) expression construct transfection (see below). HFs from an additional one female patient were used for a genome-wide microarray essay. HFs from one individual were used for isolating and culturing of K15-GFP positive cells.
Measurement of hair-growth parameters
Hair-shaft length measurements of vehicle and spermidine-treated HFs in organ culture was performed on d 0, 1, 4 and 6, using a Zeiss inverted binocular microscope with an eyepiece containing a graticule (Carl Zeiss, Oberkochen, Germany). It should be noted that hair-shaft elongation in serum-free human HF organ culture occurs at almost the same rate of normal hair growth in vivo [34]. HF cycle staging (i.e., anagen VI vs. catagen) was assessed histologically after 6 days of organ culture using hematoxylin–eosin (Sigma-Aldrich, Taufkirchen, Germany) stained frozen sections. The hair cycle stage was classified according to accepted morphological criteria [32].
Analysis of HF matrix keratinocyte proliferation and apoptosis
To evaluate apoptotic cells in colocalization with a proliferation marker Ki-67 of cells in the HF, Ki-67/TUNEL (terminal dUTP nick endlabeling) double-immunofluorescence was used as described previously [33]. Briefly, 6- µm cryosections were fixed in paraformaldehyde and ethanol-acetic acid (2[ratio]1) and labeled with a digoxigenin-deoxyUTP (ApopTag Fluorescein In Situ Apoptosis Detection Kit; Chemicon, Purchase, NY, USA) in the presence of terminal deoxynucleotidyl transferase (TdT), followed by incubation with a mouse anti-Ki-67 antiserum (Dako, Glostrup, Denmark). TUNEL-positive cells were visualized by an anti-digoxigenin FITC-conjugated antibody (ApopTag kit), whereas Ki-67 was detected by a rhodaminelabeled goat anti-mouse secondary antibody (Jackson Immuno- Research, West Grove, PA, USA). Counterstaining was performed with 4′,6-diamidino-2-phenylindole (DAPI) (Roche Molecular Biochemicals GmbH, Mannheim, Germany). Negative controls were run by omitting TdT or the primary Ki-67 antibody and by observing negative immunoreactivity for these parameters in the expected human scalp skin compartments. For the quantitative evaluation and comparison of the double-staining, DAPI-, Ki-67-, or TUNEL-positive cells were counted in clearly defined reference regions. The number of DAPI-positive cells served as “total number of cells,” and the percentage of Ki-67-positive and/or TUNEL-positive cells was calculated on this basis to enable comparison between vehicle and test groups.
ORS keratinocyte culture
Plucked HFs were digested using trypsin to obtain human ORS keratinocytes, as described previously [66]. ORS cultures were kept on a feeder layer of mitomycin-treated human dermal fibroblasts [67] in a 1[ratio]3 mixture of Ham's F12 (Biochrom, Berlin, Germany) and Dulbecco's modified Eagle's medium (Invitrogen-Life Technologies, Inc., Grand Island, NY, USA) supplemented with 0.1 nM cholera toxin, 5 µg/ml insulin, 0.4 µg/ml hydrocortisone, 2.43 µg/ml adenine, 2 nM triiodothyronine, 10 ng/ml epidermal growth factor, 1 mM ascorbyl-2-phosphate, and antibiotics (all from Sigma-Aldrich Corp.).
Quantitative immunohistochemistry of K15, K19 and ODC
Expression of K15 and K19 was studied using our previously described tyramide signal amplification protocol and basic immunohistology protocols [35]. For ODC immunohistochemistry, rabbit anti-human ODC antibody (Abnova, 1[ratio]500) was used. As negative controls for all stainings, the respective primary antibodies were omitted. In addition, morphological criteria and reproduction of the previously published HF expression pattern of K15 and K19 was used as internal positive or negative controls [35], and for ODC, expression pattern in the epidermis was used as a positive control. Densitometric measurements of staining intensities in previously defined reference areas (quantitative immunohistomorphometry) we performed using the ImageJ software (National Institute of Health, Bethesda, USA), as previously described [33]. Statistical analysis was assessed by unpaired t test, using Graph Pad Prism 5.01 (Graph Pad Software, Inc., San Diego, CA, USA).
Microarray
Gene expression analysis of HFs from two female subjects (50 HFs from each subject) using an Agilent Human Whole Genome Oligo Microarray (44K) was performed by Abiol Ltd. (Debrecen, Hungary) as a commercial service (. Freshly isolated HFs (25/group, all derived from a single donor) were treated with vehicle or 0.5 µM spermidine, and total RNA was isolated according to standard protocols (TRIzol; Invitrogen-Life Technologies). The quality of total RNA was controlled via an Agilent 2100 Bioanalyzer System (Agilent Technologies, Santa Clara, CA, USA). Linear amplification of RNA and hybridization of the whole genome oligo microarray were performed according to the manufacturer's protocols (Agilent Technologies). For analysis, after rejection of outlier features, the expressed genes showing at least 2.0-fold differential expression were further analyzed by a statistical test using the Cross-Gene Error Model based on Deviation from one (recommended by Agilent Technologies). Candidate genes were selected according to the following criteria: equidirectional expression changes in both examined individuals, value of P < 0.05, and changes ≥2-fold. All data presented in this study is MIAME compliant and the raw data have been deposited in a MIAME compliant database, the NCBI's Gene Expression Omnibus (GEO).
qPCR
Analysis of expression of specific mRNA transcripts of keratins K15, K19 and of ODC was performed by quantitative real-time PCR using the 5′ nuclease assay (ABI PRISM 7000 Sequence Detection System, Applied Biosystems, Foster City, CA, USA). Total RNA was isolated from whole HFs using TRIzol and digested with RQ1 RNase-free DNase (Promega, Madison, WI, USA) according to the manufacturer's protocol. After isolation, 1 µg of RNA was reversetranscribed into cDNA using 15 U of avian myeloblastosis virus reverse transcriptase (Promega) and 0.025 µg/µl random primers (Promega). PCR amplification was performed using TaqMan primers and probes (assay identification number: Hs00267035_m1 for K15, Hs01051611_gH for K19, and Hs00189739_m1 for ODC) using the TaqMan Gene Expression Master Mix Protocol (Applied Biosystems). A transcript of cyclophilin A (PPIA, Hs99999904_m1) was used as a housekeeping gene control. The amounts of the above-mentioned transcripts were normalized to those of the control genes using the ΔΔCt method. During normalization, the geometric mean of the Ct values of the four endogenous controls (provided that the SD of Ct values of the individual housekeeping genes, obtained in triplicate determinations, was <0.5) was used to normalize gene expression of the given gene of interest.
Isolation and in vitro studies with K15-GFP+ cells
Transfection of isolated hair follicles
Scalp skin was dissected into approximately 0.5 cm2 pieces, which were washed with PBS (37°C) to remove cell debris. These pieces were incubated overnight in Williams E Medium (Biochrom, Cambridge, UK) supplemented with 0.01% w/v reconstituted Dispase® (Invitrogen-Gibco, Grand Island, NY, USA) at 4°C. After washing with PBS, the epithelial core of single, full-length HFs were carefully plucked out from the tissue fragments with microdissection tweezers, leaving the HF dermal sheath retained in the skin. For further experiments, the HFs were collected and cultured in K-SF medium (Invitrogen-Gibco, Carlsbad, CA, USA) or directly transfected with a human K15 promoter-driven GFP expression construct as described [37], [38]. Direct immunofluorescence microscopic analysis was used to evaluate the expression of GFP. As negative controls, Dispase® treated, microdissected and only Lipofectamine® (Invitrogen, Karlsruhe, Germany) treated HFs were used. For positive controls an ubiquitously GFP expressing construct was used to transfect the HFs. All samples were viewed and photographed using a Keyence BZ 8000 fluorescence microscope. Densitometric measurements of GFP intensity and statistical analysis were performed as previously described [37], [38].
Isolation, selection and culture of human K15-GFP+ cells
To isolate and culture K15-GFP+ cells positively transfected HFs were processed as described previously [37], [38]. To test the influence of spermidine, it was added to the K15-GFP+ cell culture with an adjusted concentration of 0.1, 0.5, and 1 µM.
Semi- and quantitative RT-PCR for expression analysis of K15
Total RNA was isolated from an equivalent number of control and K15-GFP+ cells (~10.000 cells/dish) of vehicle and spermidine treated K15-GFP+ cells by using RNeasy Mini Kit (Qiagen, Germany) according to the manufacturer's protocol. Total RNA (100 ng) was reversed transcribed in 20 µl using the Perkin-Elmer RNA PCR kit (Branchburg, NJ). For quantitative analysis of K15 and the housekeeping gene ribosomal protein S26 (rS26), parts of the cDNA products (2 µl) were subjected to PCR analysis. K15 cDNA was amplified with primers K15-f (5′-GGAGGTGGAAGCCGAAGTAT-3′) and K15-r (5′-GAGAGGAGACCACCATCGCC-3′). For comparative analysis rS26 was amplified with primers rS26-f (5′-CCGTGCCTCCAAGATGACAAAG-3′) and rS26-r (5′-ACTCAGCTCCTTACATGGGCTT-3′). For quantitative qPCR expression analysis of K15, GFP and rS26 100 ng RNA was reverse transcribed in a total of 20 µl using the LightCycler® RNA-Master-SYBR-Green-I-kit and the LightCycler® 2.0 instrument (Roche). For qPCR analysis of K15 and rS26 cDNA was amplified with primers as described above. Vehicle treated K15-GFP+ cells were used as controls. For quantification analysis the LightCycler® Software 4.05 (Roche) was used. The results represent three independent experiments and data expressed as means±SEM.
Colony forming efficiency
For colony forming efficiency assays under the influence of spermidine K15-GFP+ cells were seeded onto a 35 mm culture dish coated with collagen IV and fibronectin (100 cells/well). K15-GFP+ cells were cultured as previously described [37], [38]. The analysis of the clonal potential was carried out as previously described [37], [38]. Vehicle treated K15-GFP+ cells were used as controls. The results represent 3 independent experiments and data expressed as means±SEM.
Cell proliferation
For the detection of proliferating K15-GFP+ cells after 1 day, 3 days, and 6 days under spermidine treatment, K15-, Ki-67-, and DAPI labeling was performed as described previously [37], [38]. Vehicle treated K15-GFP+ cells were used as control for the Ki-67 reaction. The results were expressed as mean percentage of treated cells compared to the vehicle control sample of 3 independent experiments and data expressed as means±SEM.
Cell proliferation assays
Primary human keratinocytes were isolated as described by Rheinwald and Green [68] from fronto-temporal scalp skin specimens, obtained with written informed consent during routine face-lift surgery (Caucasian females over 45 y). The East London and City Health Authority Research Ethics Committee approved the use of redundant human skin for this study. After isolation, keratinocytes were cultured in keratinocyte serum free medium (K-SFM) (Invitrogen, Paisley, UK) at 37°C in a humidified atmosphere of 5%CO2/95% air. Spermidine (Sigma-Aldrich, Poole, UK) was added to the culture medium at 0.1, 0.5, and 1.0 µM concentrations for 48 h. After 48 h cell proliferation was assayed using fluorometric reagent Cell Quanti Blue (BioAssay Systems, CA USA). The CellQuanti Blue reagent was diluted 1 in 10 in K-SFM and added to the cells for 1 h. Fluorescence was measured using a Bio Tek Synergy HT plate reader with KC4 software (Bio Tek, VT, USA) with a 530 nm excitation filter and a 590 nm emission filter.
Cell cycle analysis by propidium iodide flow cytometry
After 24 h +/− spermidine primary human keratinocytes were trypsinised, washed with PBS and fixed in 70% ethanol at 4°C overnight. Cells were resuspended in 50 µg/ml propidium iodide(PI) (Sigma-Aldrich), 100 µg RNaseA (Sigma-Aldrich), 3.8 mM sodium citrate in PBS and incubated at 4°C over night. For each sample 100000 cells were analysed using a LSRII flow cytometer with FACSDiva software (v 5.1.03) (both BD Biosciences, CA USA). The detector was set to linear, PI excitation at 488 nm and emission collected in the 610–620 channel, cells were gated on width and area to exclude doublets.
Acknowledgments
The excellent technical assistance of Astrid Becker and Balázs I. Tóth are gratefully acknowledged. We are also most grateful to our collaborating surgeon, Dr. Wolfgang Funk (Klinik Dr. Kozlowski, Munich, Germany), without whose generous support by the current study would not have been possible. The professional insight and generous support of Giammaria Giuliani is also gratefully acknowledged.
Footnotes
Competing Interests: RP and MP have received academic research grants from Giuliani, and have served in a consultancy function for this company. The authors are neither employees of Giuliani Srl, Milano, nor do they have any direct financial interests in the products of this company. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Funding: This study was supported in part by a research grant from Giuliani S.p.A, Milano, Italy, to Ralf Paus. Additional funding comes from Deutsche Forschungsgemeinschaft (DFG Pa 345/12-1) to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
1. Pegg AE. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J. 1986;234:249–262. [PubMed]
2. Sugiura K, Min JZ, Toyo'oka T, Inagaki S. Rapid, sensitive and simultaneous determination of fluorescence-labeled polyamines in human hair by high-pressure liquid chromatography coupled with electrospray-ionization time-of-flight mass spectrometry. J Chromatogr A. 2008;1205:94–102. [PubMed]
3. Johnson DA, Fields C, Fallon A, Fitzgerald ME, Viar MJ, et al. Polyamine-dependent migration of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2002;43:1228–1233. [PubMed]
4. McCormack SA, Viar MJ, Johnson LR. Polyamines are necessary for cell migration by a small intestinal crypt cell line. Am J Physiol. 1993;264:G367–374. [PubMed]
5. Pegg AE, McCann PP. Polyamine metabolism and function. Am J Physiol. 1982;243:C212–221. [PubMed]
6. Pietila M, Pirinen E, Keskitalo S, Juutinen S, Pasonen-Seppanen S, et al. Disturbed keratinocyte differentiation in transgenic mice and organotypic keratinocyte cultures as a result of spermidine/spermine N-acetyltransferase overexpression. J Invest Dermatol. 2005;124:596–601. [PubMed]
7. Vuohelainen S, Pirinen E, Cerrada-Gimenez M, Keinanen TA, Uimari A, et al. Spermidine is indispensable in differentiation of 3T3-L1 fibroblasts to adipocytes. J Cell Mol Med. 2009;14(6B):1683–1692. [PubMed]
8. Davidson NE, Hahm HA, McCloskey DE, Woster PM, Casero RA., Jr Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment. Endocr Relat Cancer. 1999;6:69–73. [PubMed]
9. Oredsson SM. Polyamine dependence of normal cell-cycle progression. Biochem Soc Trans. 2003;31:366–370. [PubMed]
10. Scorcioni F, Corti A, Davalli P, Astancolle S, Bettuzzi S. Manipulation of the expression of regulatory genes of polyamine metabolism results in specific alterations of the cell-cycle progression. Biochem J. 2001;354:217–223. [PubMed]
11. Ballas SK, Mohandas N, Marton LJ, Shohet SB. Stabilization of erythrocyte membranes by polyamines. Proc Natl Acad Sci USA. 1983;80:1942–1946. [PubMed]
12. Yamaguchi T, Ozaki S, Shimomura T, Terada S. Membrane perturbations of erythrocyte ghosts by spectrin release. J Biochem. 2007;141:747–754. [PubMed]
13. Kaeberlein M. Spermidine surprise for a long life. Nat Cell Biol. 2009;11:1277–1278. [PubMed]
14. Bettuzzi S, Davalli P, Astancolle S, Pinna C, Roncaglia R, et al. Coordinate changes of polyamine metabolism regulatory proteins during the cell cycle of normal human dermal fibroblasts. FEBS Lett. 1999;446:18–22. [PubMed]
15. Gugliucci A. Polyamines as clinical laboratory tools. Clin Chim Acta. 2004;344:23–35. [PubMed]
16. Moinard C, Cynober L, de Bandt JP. Polyamines: metabolism and implications in human diseases. Clin Nutr. 2005;24:184–197. [PubMed]
17. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med. 1999;341:491–497. [PubMed]
18. Schneider MR, Schmidt-Ullrich R, Paus R. The hair follicle as a dynamic miniorgan. Curr Biol. 2009;19:R132–142. [PubMed]
19. Pietila M, Parkkinen JJ, Alhonen L, Janne J. Relation of skin polyamines to the hairless phenotype in transgenic mice overexpressing spermidine/spermine N-acetyltransferase. J Invest Dermatol. 2001;116:801–805. [PubMed]
20. Soler AP, Gilliard G, Megosh LC, O'Brien TG. Modulation of murine hair follicle function by alterations in ornithine decarboxylase activity. J Invest Dermatol. 1996;106:1108–1113. [PubMed]
21. Hynd PI, Nancarrow MJ. Inhibition of polyamine synthesis alters hair follicle function and fiber composition. J Invest Dermatol. 1996;106:249–253. [PubMed]
22. Fashe T, Keinänen T, Grigorenko N, Khomutov A, Jänne J, et al. Cutaneous application of α-Methylspermidine activates the growth of resting hair follicles in mice. Amino Acid. 2009;38(2):583–590. [PubMed]
23. Coleman CS, Pegg AE, Megosh LC, Guo Y, Sawicki JA, et al. Targeted expression of spermidine/spermine N1-acetyltransferase increases susceptibility to chemically induced skin carcinogenesis. Carcinogenesis. 2002;23:359–364. [PubMed]
24. Megosh L, Gilmour SK, Rosson D, Soler AP, Blessing M, et al. Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res. 1995;55:4205–4209. [PubMed]
25. Panteleyev AA, Christiano AM, O'Brien TG, Sundberg JP. Ornithine decarboxylase transgenic mice as a model for human atrichia with papular lesions. Exp Dermatol. 2000;9:146–151. [PubMed]
26. Pietila M, Alhonen L, Halmekyto M, Kanter P, Janne J, et al. Activation of polyamine catabolism profoundly alters tissue polyamine pools and affects hair growth and female fertility in transgenic mice overexpressing spermidine/spermine N1-acetyltransferase. J Biol Chem. 1997;272:18746–18751. [PubMed]
27. Smith MK, Trempus CS, Gilmour SK. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin. Carcinogenesis. 1998;19:1409–1415. [PubMed]
28. Suppola S, Pietila M, Parkkinen JJ, Korhonen VP, Alhonen L, et al. Overexpression of spermidine/spermine N1-acetyltransferase under the control of mouse metallothionein I promoter in transgenic mice: evidence for a striking post-transcriptional regulation of transgene expression by a polyamine analogue. Biochem J. 1999;338(Pt 2):311–316. [PubMed]
29. Ramot Y, Pietila M, Giuliani G, Rinaldi F, Alhonen L, et al. Polyamines and hair: a couple in search of perfection. Exp Dermatol. 2010;19(9):784–790. [PubMed]
30. Hamzavi I, Tan E, Shapiro J, Lui H. A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol. 2007;57:54–59. [PubMed]
31. Wolf JE, Jr, Shander D, Huber F, Jackson J, Lin CS, et al. Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. Int J Dermatol. 2007;46:94–98. [PubMed]
32. Kloepper JE, Sugawara K, Al-Nuaimi Y, Gaspar E, van Beek N, et al. Methods in hair research: how to objectively distinguish between anagen and catagen in human hair follicle organ culture. Exp Dermatol. 2010;19(3):305–312. [PubMed]
33. Gaspar E, Hardenbicker C, Bodo E, Wenzel B, Ramot Y, et al. Thyrotropin releasing hormone (TRH): a new player in human hair-growth control. FASEB J. 2009;24:373–403. [PubMed]
34. Philpott MP, Sanders D, Westgate GE, Kealey T. Human hair growth in vitro: a model for the study of hair follicle biology. J Dermatol Sci. 1994;7(Suppl):S55–72. [PubMed]
35. Ramot Y, Bíró T, Tiede S, Tóth BI, Langan EA, et al. Prolactin-a novel neuroendocrine regulator of human keratin expression in situ. FASEB J. 2010;24:1768–1779. [PubMed]
36. Pales JL, Lopez A, Vidal S. Effects of polyamines on platelet aggregation. Scand J Haematol. 1984;32:241–244. [PubMed]
37. Tiede S, Bohm K, Meier N, Funk W, Paus R. Endocrine controls of primary adult human stem cell biology: Thyroid hormones stimalute keratin 15 expression, apoptosis, and differentiation in human hair follicle epithelial stem cells in situ and in vitro. Eur J Cell Biol. 2010;89:769–777. [PubMed]
38. Tiede S, Koop N, Kloepper JE, Fassler R, Paus R. Nonviral in situ green fluorescent protein labeling and culture of primary, adult human hair follicle epithelial progenitor cells. Stem Cells. 2009;27:2793–2803. [PubMed]
39. Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, et al. Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest. 2006;116:249–260. [PMC free article] [PubMed]
40. Paus R, Foitzik K. In search of the “hair cycle clock”: a guided tour. Differentiation. 2004;72:489–511. [PubMed]
41. Foitzik K, Krause K, Conrad F, Nakamura M, Funk W, et al. Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol. 2006;168:748–756. [PubMed]
42. Sugawara K, Schneider MR, Dahlhoff M, Kloepper JE, Paus R. Cutaneous consequences of inhibiting EGF receptor signaling in vivo: normal hair follicle development, but retarded hair cycle induction and inhibition of adipocyte growth in Egfr(Wa5) mice. J Dermatol Sci. 2010;57:155–161. [PubMed]
43. Nancarrow MJ, Nesci A, Hynd PI, Powell BC. Dynamic expression of ornithine decarboxylase in hair growth. Mech Dev. 1999;84:161–164. [PubMed]
44. Mehnert M, Sommer T, Jarosch E. ERAD ubiquitin ligases: multifunctional tools for protein quality control and waste disposal in the endoplasmic reticulum. Bioessays. 2010;32:905–913. [PubMed]
45. Liu Y, Hu Y, Li X, Niu L, Teng M. The crystal structure of the human nascent polypeptide-associated complex domain reveals a nucleic acid-binding region on the NACA subunit. Biochemistry. 2010;49:2890–2896. [PubMed]
46. Mayr JA, Merkel O, Kohlwein SD, Gebhardt BR, Bohles H, et al. Mitochondrial phosphate-carrier deficiency: a novel disorder of oxidative phosphorylation. Am J Hum Genet. 2007;80:478–484. [PubMed]
47. Kim M, Jang HR, Haam K, Kang TW, Kim JH, et al. Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer. Carcinogenesis. 2010;31:1685–1693. [PubMed]
48. Cotsarelis G. Epithelial stem cells: a folliculocentric view. J Invest Dermatol. 2006;126:1459–1468. [PubMed]
49. Tjabringa GS, Zandieh-Doulabi B, Helder MN, Knippenberg M, Wuisman PI, et al. The polymine spermine regulates osteogenic differentiation in adipose stem cells. J Cell Mol Med. 2008;12:1710–1717. [PubMed]
50. Hu X, Washington S, Verderame MF, Manni A. Interaction between Polyamines and the Mitogen-Activated Protein Kinase Pathway in the Regulation of Cell Cycle Variables in Breast Cancer Cells. Cancer Res. 2005;65:11026–11033. [PubMed]
51. Nasizadeh S, Myhre L, Thiman L, Alm K, Oredsson S, et al. Importance of polyamines in cell cycle kinetics as studied in a transgenic system. Exp Cell Res. 2005;308:254–264. [PubMed]
52. Kloepper JE, Tiede S, Brinckmann J, Reinhardt DP, Meyer W, et al. Immunophenotyping of the human bulge region: the quest to define useful in situ markers for human epithelial hair follicle stem cells and their niche. Exp Dermatol. 2008;17:592–609. [PubMed]
53. Pegg AE. Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator. Am J Physiol Endocrinol Metab. 2008;294:E995–1010. [PubMed]
54. Paus R, Olsen EA, Messenger A. Hair Growth Disorders. In: Wolff K GL, Katz SI, Gilchrest B, Paller AS, Leffell DJ, editors. New York: Fitzpatrick's Dermatology in General Medicine; 2008. pp. 753–777.
55. Nancarrow MJ, Powell BC, Hynd PI. Expression of ornithine decarboxylase during embryonic development of wool follicles. Exp Dermatol. 1999;8:326–328. [PubMed]
56. Langbein L, Schweizer J. Keratins of the human hair follicle. Int Rev Cytol. 2005;243:1–78. [PubMed]
57. Gerner EW, Meyskens FL., Jr Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer. 2004;4:781–792. [PubMed]
58. Thomas T, Thomas TJ. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci. 2001;58:244–258. [PubMed]
59. Eisenberg T, Knauer H, Schauer A, Buttner S, Ruckenstuhl C, et al. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol. 2009;11:1305–1314. [PubMed]
60. Paus R. A neuroendocrinological perspective on human hair follicle pigmentation. Pigment Cell Melanoma Res. 2011;24:89–106. [PubMed]
61. Bodo E, Tobin DJ, Kamenisch Y, Biro T, Berneburg M, et al. Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy. Am J Pathol. 2007;171:1153–1167. [PubMed]
62. Harries MJ, Paus R. The pathogenesis of primary cicatricial alopecias. Am J Pathol. 2010;177:2152–2162. [PubMed]
63. Childs AC, Mehta DJ, Gerner EW. Polyamine-dependent gene expression. Cell Mol Life Sci. 2003;60:1394–1406. [PubMed]
64. Sundberg JP, Erickson AA, Roop DR, Binder RL. Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10. Cancer Res. 1994;54:1344–1351. [PubMed]
65. Palmieri F. The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch. 2004;447:689–709. [PubMed]
66. Limat A, Noser FK. Serial cultivation of single keratinocytes from the outer root sheath of human scalp hair follicles. J Invest Dermatol. 1986;87:485–488. [PubMed]
67. Limat A, Hunziker T, Boillat C, Bayreuther K, Noser F. Post-mitotic human dermal fibroblasts efficiently support the growth of human follicular keratinocytes. J Invest Dermatol. 1989;92:758–762. [PubMed]
68. Rheinwald JG, Green H. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature. 1977;265:421–424. [PubMed]
69. Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol. 2008;129:705–733. [PMC free article] [PubMed]
70. Gingold-Belfer R, Bergman M, Alcalay Y, Schlesinger H, Aravot D, et al. Popeye domain-containing 1 is down-regulated in failing human hearts. Int J Mol Med. 2011;27:25–31. [PubMed]
Articles from PLoS ONE are provided here courtesy of
Public Library of Science